1. EUROPEAN PARTNERSHIP FOR ACTION AGAINST CANCER
National Institute of Public Health, Slovenia
Marija Seljak, Sandra Radoš Krnel,
Tit Albreht, Marjetka Jelenc,
Tina Lipušček…

2. Introduction
Cancer is the second most common cause of death in Europe, accounting for 29% of deaths in men and 23% in women
For successful action at EU level it is important that many partners as all three institutions – the Parliament, the Council, the Commission – patient organisations, professionals and many others actively contribute.

3. The initial "Europe Against Cancer" programmes were valuable in putting in place the first elements of a European strategy to combat cancer.
Now it is needed a broader strategy to tackle cancer more efficiently, bringing together a wide range of stakeholders, to take concrete actions to prevent and control cancer.

4. In March 2006 Slovenia announced Reducing the Burden of Cancer in EU a target during its Presidency
This decision was not made randomly, as cancer certainly represents one of the biggest public health issues
In spite of the important magnitude of this problem, yet the public health response to this major threat was and still is fragmented

5. Reducing the Burden of Cancer in EU as a leading theme
Offers an important opportunity to reassess:
how Member States are responding to the public health challenge of cancer as a chronic disease, and
to develop an action oriented, integrated and multisectoral policy response

6. Slovenian EU Presidency Conference “The Burden of Cancer
How can it be Reduced” Brdo , 7-8 February 2008

7. The Council Conclusions
Under SI Presidency:
The EC was asked to present an EU Action Plan on Cancer, which will address all aspects of comprehensive cancer control, through a multidisciplinary approach and consider the appropriate framework for effective cancer control policies and sharing best practices in cancer prevention and care.
Under BE Presidency:
Council welcomed the Commission's initiative of setting up a joint action to take the Partnership forward and the active participation of all Member States in it

8. EC
In 2009 the Commission issued the Communication, which lays down the foundations of the European Partnership for Action Against Cancer
The European Partnership for Action Against Cancer was launched in September 2009

9. EPAAC The overall aim is to support Member States
The Partnership approach should also contribute to avoiding duplication of efforts, and thus help to make better use of limited resources
The overall objective:
MS should have integrated cancer plans
This should contribute to achieving the long-term aim which is to reduce cancer incidence by 15% by 2020

10. Joint Action
The work is to be taken forward through a specific financial mechanism under the EU Health Programme – a "joint action”
Slovenia took the leadership and coordinated partners in the project

11. SI.NERGY We can only be successful if our work is complementary;
More synergy among the Member States, European institutions and civil society, as well as international organisations at the global level.

12. EUROPEAN PARTNERSHIP FOR ACTION AGAINST CANCER WORK PACKAGE 1, COORDINATION

13. RESPONSIBILITIES
To ensure that the Joint Action, milestones progress according to plan
Constant monitoring of WPLs
Management of the budget
Delivery of interim and final technical and financial reports to the EAHC

14. JA GOVERNANCE STRUCTURE
JA MANAGEMENT TEAM
JA ADVISORY COMMITTEE
PARTNERSHIP STEERING COMMITTEE

15. JA MANAGEMENT TEAM
Responsible for overall organisation, financial and technical reporting
Liaison between all partners and EAHC, EC
Day to day management
Who? A team of 5-7 people from NIPH, Slovenia

16. JA ADVISORY COMMITTEE Advise MT on general direction of JA
Perform review of progress, provide guidance, promote exposure of JA
Who? The MT and all Work Package Leaders (WPLs).

17. PARTNERSHIP STEERING COMMITTEE
Review and confirm decisions made by the AC, oversight committee
Final confirmation of all plans, literally ‘steer’ JA in light of its goals and work plan
Special attention paid to National Cancer Plans
Who? All WPLs, reps. from all 27 EU MSs, plus Iceland & Norway, EC, IARC, EOHSP, ECPC, ECCO, industry assoc., WHO Europe, EUREGHA, individual experts.